Document:

EX-4.6

 Exhibit 4.6 

Execution Version 
 HRTI,
LLC 
 and 
 TRUIST BANK 

as Trustee 
  

 
 Tenth
Supplemental Indenture 
 Dated as of July 22, 2022 
  

 
 Supplement to
Indenture dated as of May 15, 2001 
  

 Tenth Supplemental Indenture 

Tenth Supplemental Indenture, dated as of July 22, 2022, between HRTI, LLC, a Maryland limited liability company
(formerly known as Healthcare Realty Trust Incorporated, a Maryland corporation) (hereinafter called the “Company” or “HR”), having its principal office at 3310 West End Avenue, Suite 700, Nashville, Tennessee
37203, and Truist Bank (formerly known as Branch Banking and Trust Company), a bank organized and existing under the laws of the state of North Carolina, as Trustee (hereafter called the “Trustee”), having a Corporate Trust Office
at 2713 Forest Hills Road, Bldg 2 Fl 2, Wilson, North Carolina 27893 as Trustee under the Indenture (as hereinafter defined). 
 Recitals

 Whereas, the Company and the Trustee are parties to an Indenture, dated as of May 15, 2001, a copy of which is
attached hereto as Exhibit A and which is incorporated herein by reference (hereinafter called the “HR Base Indenture”), as amended and supplemented by the First Supplemental Indenture, dated as of May 15, 2001, the
Second Supplemental Indenture, dated as of March 30, 2004, the Third Supplemental Indenture, dated as of December 4, 2009, the Fourth Supplemental Indenture, dated as of December 13, 2010, the Fifth Supplemental Indenture, dated as of
March 26, 2013, the Sixth Supplemental Indenture, dated as of April 24, 2015, a copy of which is attached hereto as Exhibit B and which is incorporated herein by reference (the “Sixth Supplemental Indenture”), the
Seventh Supplemental Indenture, dated as of December 11, 2017, a copy of which is attached hereto as Exhibit C and which is incorporated herein by reference (the “Seventh Supplemental Indenture”), the Eighth Supplemental
Indenture, dated as of March 18, 2020, a copy of which is attached hereto as Exhibit D and which is incorporated herein by reference (the “Eighth Supplemental Indenture”), and the Ninth Supplemental Indenture, dated as
of October 2, 2020, a copy of which is attached hereto as Exhibit E and which is incorporated herein by reference (the “Ninth Supplemental Indenture”; and, the HR Base Indenture as so amended and supplemented by such
supplemental indentures, the “Indenture”), providing for the issuance by the Company from time to time of its senior debt securities evidencing its unsecured and unsubordinated indebtedness (the “Securities”); 

Whereas, HR and Healthcare Trust of America, Inc. (“HTA”) have entered into an agreement and plan of merger
(the “Merger Agreement”), by and among HR, HTA, Healthcare Trust of America Holdings, LP (“HTA OP”) and HR Acquisition 2, LLC (“Merger Sub”), pursuant to which the combination of HTA and the Company
will be accomplished through a merger of Merger Sub with and into the Company, with the Company continuing as the surviving entity and a subsidiary of HTA (the “Merger”); 

Whereas, HTA OP has offered holders of 3.875% Senior Notes due 2025 (the “2025 Notes”), 3.625% Senior Notes
due 2028 (the “2028 Notes”), 2.400% Senior Notes due 2030 (the “2030 Notes”) and 2.050% Senior Notes due 2031 (the “2031 Notes” and, collectively with the 2025 Notes, the 2028 Notes and the 2030
Notes, the “Notes”), each such series of notes having been issued by HR, to exchange (the “HTA Exchange Offer”) any and all of the Notes for corresponding series of notes of HTA OP on the terms and subject to the
conditions set forth in the prospectus relating to the offers to exchange and solicitations of consents, including consummation of the Merger, dated as of June 28, 2022 (the “Prospectus”), forming a part of the Registration
Statement on Form S-4, filed by HTA and HTA OP with the Securities and Exchange Commission (the “SEC”) on June 14, 2022 and declared effective by the SEC on June 28, 2022; 

Whereas, Section 902 of the HR Base Indenture provides that, with the consent of the holders of not less than a majority
in principal amount of all the outstanding securities of each series affected by such supplemental indenture, voting as separate classes (the “Requisite Consents”), the Company, when authorized by a Board Resolution, and the Trustee
may enter into an indenture supplemental to the Indenture for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of the Indenture, subject to certain enumerated exceptions set forth therein which
require the consent of the holder of each outstanding security affected thereby (which such exceptions do not apply with respect to the Proposed Amendments (as defined below)); 

  
 -1- 

 Whereas, in connection with the HTA Exchange Offer, HTA OP has also
solicited consents from holders of the Notes to certain amendments (the “Proposed Amendments”) to the Indenture as described in the Prospectus and set forth in Article One of this Tenth Supplemental Indenture; 

Whereas, HTA OP has received and caused to be delivered to the Trustee evidence of the consents from holders of a majority of
the outstanding aggregate principal amount of each series of the Notes, voting as separate classes, to effect the Proposed Amendments under the Indenture; 

Whereas, the Company is undertaking to execute and deliver this Tenth Supplemental Indenture to delete or amend, as
applicable, certain provisions and covenants in the Indenture; and 
 Whereas, the Company and the Trustee deem it advisable
to enter into this Tenth Supplemental Indenture for the purposes of providing for the rights, obligations and duties of the Company and the Trustee with respect to the Notes and to set forth certain specific provisions with respect thereto. 

NOW, THEREFORE, THIS TENTH SUPPLEMENTAL
INDENTURE WITNESSETH: 
 For and in consideration of the premises, the Company and the Trustee
covenant and agree, for the equal and proportionate benefit of all Holders of the Notes, as follows: 
 Article One. 

Amendments 

From and after the Effective Date (as defined below), the HR Base Indenture, the Sixth Supplemental Indenture, the Seventh
Supplemental Indenture, the Eighth Supplemental Indenture, and the Ninth Supplemental Indenture are hereby amended as follows: 

Section 1.01. Reports by the Company. With respect to the Notes, Section 703 of the HR
Base Indenture is deleted in its entirety and replaced with the following: 
  

	 	(a)	 Section 703 [Intentionally Omitted]. 

Section 1.02. Covenants and Other Provisions in HR Base Indenture. With respect to the Notes,
all of the sections or provisions listed below under the HR Base Indenture are deleted in their entirety and replaced, respectively, with the following: 
  

	 	(a)	 Section 501(5) [Intentionally Omitted]. 

 

	 	(b)	 Section 801 [Intentionally Omitted]. 

 

	 	(c)	 Section 802 [Intentionally Omitted]. 

 

	 	(d)	 Section 803 [Intentionally Omitted]. 

 

	 	(e)	 Section 1005 [Intentionally Omitted]. 

  
 -2- 

	 	(f)	 Section 1006 [Intentionally Omitted]. 

 

	 	(g)	 Section 1007 [Intentionally Omitted]. 

 

	 	(h)	 Section 1008 [Intentionally Omitted]. 

 

	 	(i)	 Section 1009 [Intentionally Omitted]. 

 

	 	(j)	 Section 1010 [Intentionally Omitted]. 

Section 1.03. Covenants in Sixth Supplemental Indenture. Solely with respect to the 2025
Notes, all of the sections or provisions listed below under the Sixth Supplemental Indenture relating to the 2025 Notes are deleted in their entirety and replaced, respectively, with the following: 

 

	 	(a)	 Section 4.01 [Intentionally Omitted]. 

 

	 	(b)	 Section 4.02 [Intentionally Omitted]. 

 

	 	(c)	 Section 4.03 [Intentionally Omitted]. 

 

	 	(d)	 Section 4.04 [Intentionally Omitted]. 

Section 1.04. Covenants in Seventh Supplemental Indenture. Solely with respect to the 2028
Notes, all of the sections or provisions listed below under the Seventh Supplemental Indenture relating to the 2028 Notes are deleted in their entirety and replaced, respectively, with the following: 

 

	 	(a)	 Section 4.01 [Intentionally Omitted]. 

 

	 	(b)	 Section 4.02 [Intentionally Omitted]. 

 

	 	(c)	 Section 4.03 [Intentionally Omitted]. 

 

	 	(d)	 Section 4.04 [Intentionally Omitted]. 

Section 1.05. Covenants in Eighth Supplemental Indenture. Solely with respect to the 2030
Notes, all of the sections or provisions listed below under the Eighth Supplemental Indenture relating to the 2030 Notes are deleted in their entirety and replaced, respectively, with the following: 

 

	 	(a)	 Section 4.01 [Intentionally Omitted]. 

 

	 	(b)	 Section 4.02 [Intentionally Omitted]. 

 

	 	(c)	 Section 4.03 [Intentionally Omitted]. 

 

	 	(d)	 Section 4.04 [Intentionally Omitted]. 

Section 1.06. Covenants in Ninth Supplemental Indenture. Solely with respect to the 2031
Notes, all of the sections or provisions listed below under the Ninth Supplemental Indenture relating to the 2031 Notes are deleted in their entirety and replaced, respectively, with the following: 

 

	 	(a)	 Section 4.01 [Intentionally Omitted]. 

  
 -3- 

	 	(b)	 Section 4.02 [Intentionally Omitted]. 

 

	 	(c)	 Section 4.03 [Intentionally Omitted]. 

 

	 	(d)	 Section 4.04 [Intentionally Omitted]. 

Section 1.07. Effects of Sections 1.01 through 1.06. Any and all references to any Articles
and Sections of the Indenture which are deleted by any Article or Section of this Tenth Supplemental Indenture, and any and all obligations related solely to such deleted Articles or Sections throughout the Indenture, with respect to the applicable
series of Notes, are of no further force or effect. Any and all terms defined in the Indenture or Notes which are (i) used in any Articles or Sections of the Indenture or Notes deleted by any Article or Section of this Tenth Supplemental
Indenture and (ii) not otherwise used in any other Article or Section of the Indenture or Notes not affected by this Tenth Supplemental Indenture are hereby deleted. 

Article Two. 

Effectiveness 

Section 2.01. Requisite Consents having been received, this Tenth Supplemental Indenture shall
become a binding agreement between the parties hereto when executed by the parties hereto. Notwithstanding the foregoing, the amendments to the HR Base Indenture, the Sixth Supplemental Indenture, the Seventh Supplemental Indenture, the Eighth
Supplemental Indenture, and the Ninth Supplemental Indenture set forth herein shall become effective only on and as of the date on which each of the following has been satisfied (the “Effective Date”): (a) HTA OP has delivered to
the Trustee for all validly tendering holders of the Notes (who have not validly withdrawn such tenders) the aggregate amount to be paid to such validly tendering holders the Total Consideration or Exchange Consideration, as applicable and as each
is defined in the Prospectus, upon the terms and subject to the conditions in the Prospectus, due to such validly tendering holders, (b) HTA OP notifies the Trustee that the Notes that are validly tendered (and not validly withdrawn) have been
accepted for exchange by HTA OP in accordance with the terms of the Prospectus, and (c) the Merger shall have been consummated. 

Article Three. 

Miscellaneous 

Section 3.01. Each and every term and condition contained in the Indenture shall apply to this Tenth
Supplemental Indenture with the same force and effect as if the same were herein set forth in full, with such omissions, variations and modifications thereof as may be appropriate to make the same conform to this Tenth Supplemental Indenture. As
supplemented by this Tenth Supplemental Indenture, the Indenture shall be read, taken and construed as one and the same instrument; provided, however, that the rights, duties and obligations of the Trustee in this Tenth Supplemental Indenture
shall be limited to those matters expressly relating to the Notes. The permissive rights of the Trustee to take any action under this Tenth Supplemental Indenture or the Indenture shall not be construed as duties. 

Section 3.02. Nothing contained in this Tenth Supplemental Indenture shall be construed to confer
upon any person other than a Holder of the Notes, the Company and the Trustee any right or interest to avail itself or himself, as the case may be, of any benefit under any provision of the Indenture or this Tenth Supplemental Indenture. 

Section 3.03. All capitalized terms which are used herein and not otherwise defined herein are
defined in the Indenture and are used herein with the same meanings as set forth in the Indenture. 

  
 -4- 

 Section 3.04. This Tenth Supplemental Indenture
shall be effective as of the date first above written and upon the execution and delivery hereof by each of the parties hereto. 

Section 3.05. This Tenth Supplemental Indenture shall be governed by, and construed in accordance
with, the laws of the State of New York. 
 Section 3.06. This Tenth Supplemental Indenture may be
executed in any number of counterparts, each of which so executed shall be deemed to be an original but all such counterparts shall together constitute but one and the same instrument. The words “execution,” “signed,”
“signature,” and words of like import in this Tenth Supplemental Indenture or in any other certificate, agreement or document related to this Tenth Supplemental Indenture or the Notes shall include images of manually executed signatures
transmitted by facsimile or other electronic format (including, without limitation, “pdf”, “tif” or “jpg”) and other electronic signatures (including, without limitation, DocuSign and AdobeSign). The use of electronic
signatures and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as a
manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures
and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform Commercial Code. 

Section 3.07. This Tenth Supplemental Indenture shall cease to be of further effect upon compliance
with Section 401 of the Indenture with respect to the Notes. 
 Section 3.08. The provisions
of this Tenth Supplemental Indenture shall only be applicable with respect to, and govern the terms of, the Notes and shall not apply to any other Securities that may be issued by the Company under the Indenture. 

Section 3.09. In case any one or more of the provisions contained in this Tenth Supplemental
Indenture or in the Notes shall for any reason be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Tenth Supplemental Indenture or of the
Notes, but this Tenth Supplemental Indenture and the Notes shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein or therein. 

(signature page follows) 

  
 -5- 

 In Witness Whereof, the parties hereto have caused this Tenth Supplemental
Indenture to be duly executed by their respective officers hereunto duly authorized, all as of the day and year first above written. 
  

					
	 Dated: July 22, 2022
	 		 	 HRTI, LLC
  

By:                       
                                         
                                         
         
 Name: B. Douglas Whitman, II

Title: Senior Vice President, Finance and Treasurer

			
	 Dated: July 22, 2022
	 		 	 Truist Bank, as Trustee
  

By:                       
                                         
                                         
         
 Name: Susan K. Baker

Title: Vice President

 Acknowledgment 

State of __________ ) 

              ) SS: 

County of ________ ) 

On the 22nd day of July, 2022, before me personally came B. Douglas
Whitman, II, to me known, who, being by me duly sworn, did depose and say that he is the Senior Vice President, Finance and Treasurer of HRTI, LLC, one of the parties described in and which executed the foregoing instrument, and that he signed his
name thereto by authority of the Board of Directors. 
 [Notarial Seal] 

 
  

Notary Public 
 Commission Expires 

State of __________ ) 

              ) SS: 

County of ________ ) 

On the 22nd day of July, 2022, before me personally came Susan K. Baker,
to me known, who, being by me duly sworn, did depose and say that she is a Vice President of TRUIST BANK, one of the parties described in and which executed the foregoing instrument, and that she signed her name thereto
by authority of the Board of Directors. 
 [Notarial Seal] 
  

 
 Notary Public 

Commission Expires 

  

 Exhibit A 

HR Base Indenture 

Incorporated by reference to the Company’s Form 8-K filed with the Securities and
Exchange Commission on May 17, 2001. 

 Exhibit B 

Sixth Supplemental Indenture 

Incorporated by reference to the Company’s Form 8-K filed with the Securities and
Exchange Commission on April 24, 2015. 

 Exhibit C 

Seventh Supplemental Indenture 

Incorporated by reference to the Company’s Form 8-K filed with the Securities and
Exchange Commission on December 11, 2017. 

 Exhibit D 

Eighth Supplemental Indenture 

Incorporated by reference to the Company’s Form 8-K filed with the Securities and
Exchange Commission on March 18, 2020. 

 Exhibit E 

Ninth Supplemental Indenture 

Incorporated by reference to the Company’s Form 8-K filed with the Securities and
Exchange Commission on October 2, 2020.EX-4.7

 Exhibit 4.7 

THIS GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING THIS NOTE) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE
BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (1) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY BE REQUIRED PURSUANT TO SECTION 2.06 OF THE INDENTURE,
(2) THIS GLOBAL NOTE MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.06(a) OF THE INDENTURE, (3) THIS GLOBAL NOTE MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 2.09 OF THE INDENTURE AND
(4) THIS GLOBAL NOTE MAY BE TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN CONSENT OF THE ISSUER. 
 UNLESS AND UNTIL IT
IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE
DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (55 WATER STREET, NEW YORK,
NEW YORK) (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS MAY BE REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR SUCH OTHER ENTITY AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

 HEALTHCARE REALTY HOLDINGS, L.P. 

3.875% Senior Notes due 2025 
  

			
	 No. 2025-1
	  	
		
	 CUSIP No.:
	  	 42225UAJ3

		
	 ISIN:
	  	 US42225UAJ34

 $235,016,000 

Healthcare Realty Holdings, L.P., a Delaware limited partnership (f/k/a Healthcare Trust of America Holdings, LP, a Delaware
limited partnership) (herein called the “Issuer,” which term includes any successor entity under the Indenture referred to on the reverse hereof), for value received hereby promises to pay to Cede & Co., or its registered
assigns, the principal sum of two hundred thirty five million, sixteen thousand dollars ($235,016,000), or such lesser amount as is set forth in the Schedule of Exchanges of Interests in the Global Note on the other side of this Note, on May 1,
2025 at the office or agency of the Issuer maintained for that purpose in accordance with the terms of the Indenture, in such coin or currency of the United States of America as at the time of payment shall be legal tender for the payment of public
and private debts, and to pay interest, semi-annually on May 1 and November 1 of each year, commencing November 1, 2022, on said principal sum at said office or agency, in like coin or currency, at the rate per annum of 3.875%, from
the May 1 and November 1 as the case may be, next preceding the date to which interest has been paid or duly provided for, and in the case of the first interest payment on the Notes, from May 1, 2022, until payment of said principal
sum has been made or duly provided for. The Issuer shall pay interest on any Notes in certificated form by check mailed to the address of the Person entitled thereto as it appears in the Note Register; provided, however, that a Holder
of any Notes in certificated form in the aggregate principal amount of more than $2.0 million may specify by written notice to the Issuer that it pay interest by wire transfer of immediately available funds to the account specified by the
Noteholder in such notice, or on any Global Note by wire transfer of immediately available funds to the account of the Depositary or its nominee. 

The Issuer promises to pay interest on overdue principal, premium, if any, and (to the extent that payment of such interest is
enforceable under applicable law) interest at the rate of 1% per annum above the rate borne by the Notes. 
 Reference is
made to the further provisions of this Note set forth on the reverse hereof and the Indenture governing this Note. Such further provisions shall for all purposes have the same effect as though fully set forth at this place. 

This Note shall not be valid or become obligatory for any purpose until the certificate of authentication hereon shall have
been signed manually or by facsimile or other electronic imaging means by the Trustee or a duly authorized authenticating agent under the Indenture. 

 IN WITNESS WHEREOF, the Issuer has caused this Note to be duly executed.

 Dated: July 22, 2022 
  

			
	 HEALTHCARE REALTY HOLDINGS, L.P.

		
	 By:
	 	 Healthcare Realty Trust Incorporated,

		 	 its general partner

		
	 By:
	 	 /s/ J. Christopher Douglas

		 	 Name: J. Christopher Douglas

		 	 Title: Chief Financial Officer

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Notes described in the within-named Indenture. 

Dated: July 22, 2022 
  

			
	 U.S. Bank Trust Company, National Association, as Trustee

		
	 By:
	 	 /s/ Mary Ambriz-Reyes

	 Authorized Signatory

 [REVERSE SIDE OF NOTE] 

Healthcare Realty Holdings, L.P. 

3.875% Senior Notes Due 2025 

This Note is one of a duly authorized issue of Notes of the Issuer, designated as its 3.875% Senior Notes Due 2025 (herein
called the “Notes”), issued under and pursuant to an Indenture dated as of July 22, 2022 (herein called the “Base Indenture”), as supplemented by Supplemental Indenture No. 1 dated as of July 22, 2022
(“First Supplemental Indenture” and together, the “Indenture”), among the Issuer, the Guarantor and U.S. Bank Trust Company, National Association, as trustee (herein called the
“Trustee”), to which Indenture and any indentures supplemental thereto reference is hereby made for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Issuer, the
Guarantor and the Holders of the Notes. Defined terms used but not otherwise defined in this Note shall have the respective meanings ascribed thereto in the Indenture. 

If an Event of Default (other than an Event of Default specified in Section 6.01(e), 6.01(f)
or 6.01(g) of the Indenture with respect to the Issuer) occurs and is continuing, the principal of, premium, if any, and accrued and unpaid interest on all Notes may be declared to be due and payable by either the Trustee or the Holders of at
least twenty five percent (25%) in aggregate principal amount of the Notes then outstanding, and, upon said declaration the same shall be immediately due and payable. If an Event of Default specified in Section 6.01(e),
6.01(f) or 6.01(g) of the Indenture occurs with respect to the Issuer, the principal of and premium, if any, and interest accrued and unpaid on all the Notes shall be immediately and automatically due and payable without necessity of
further action. 
 The Indenture contains provisions permitting the Issuer and the Trustee, with the consent of the Holders
of not less than a majority in aggregate principal amount of the Notes at the time outstanding, to execute supplemental indentures adding any provisions to or changing in any manner or eliminating any of the provisions of the Indenture or of any
supplemental indenture or modifying in any manner the rights of the Holders of the Notes, subject to exceptions set forth in Section 9.02 of the Base Indenture. Subject to the provisions of the Indenture, the Holders of not
less than a majority in aggregate principal amount of the Notes at the time outstanding may, on behalf of the Holders of all of the Notes, waive any past Default or Event of Default, subject to exceptions set forth in the Indenture. 

No reference herein to the Indenture and no provision of this Note or of the Indenture shall impair, as among the Issuer and
the Holder of the Notes, the obligation of the Issuer, which is absolute and unconditional, to pay the principal of, premium, if any, on and interest on this Note at the place, at the respective times, at the rate and in the coin or currency herein
and in the Indenture prescribed. 
 Interest on the Notes shall be computed on the basis of a
360-day year of twelve 30-day months. 

 The Notes are issuable in fully registered form, without coupons, in
denominations of $2,000 principal amount and any multiple of $1,000. At the office or agency of the Issuer referred to on the face hereof, and in the manner and subject to the limitations provided in the Indenture, without payment of any service
charge but with payment of a sum sufficient to cover any tax, assessment or other governmental charge that may be imposed in connection with any registration or exchange of Notes, Notes may be exchanged for a like aggregate principal amount of Notes
of any other authorized denominations. 
 The Issuer shall have the right to redeem the Notes under certain circumstances as
set forth in Sections 3.01, 3.02 and 3.03 of the Indenture. 
 The Notes are not subject to redemption
through the operation of any sinking fund. 
 Except as expressly provided in Article 15 of the Indenture, no
recourse for the payment of the principal of or any premium or interest on this Note, or for any claim based hereon or otherwise in respect hereof, and no recourse under or upon any obligation, covenant or agreement of the Issuer in the Indenture or
any supplemental indenture or in any Note, or because of the creation of any indebtedness represented thereby, shall be had against any incorporator, stockholder, limited partner, member, manager, employee, agent, officer, director or subsidiary, as
such, past, present or future, of the Guarantor, the Issuer or any of the Issuer’s Subsidiaries or of any successor thereto, either directly or through the Guarantor, the Issuer or any of the Issuer’s subsidiaries or of any successor
thereto, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that all such liability is hereby expressly waived and released as a condition of,
and as consideration for, the execution of the Indenture and the issue of this Note. 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 
  

			
	 (I) or (we) assign and transfer this Note to:
	 	  

		 	             (Insert assignee’s legal name)

  
  

(Insert assignee’s soc. sec. or tax I.D. no.) 
  

 
  

 
  

 
  

 
 (Print or type assignee’s name,
address and zip code) 
 and irrevocably appoint
                                         
                                         
                                         
                                         
             to transfer this Note on the books of the Issuer. The agent may substitute another to act for him. 

Date:
                         
  

					
	Your Signature:	  	  

	(Sign exactly as your name appears on the face of this Note)

 Signature Guarantee*:
                 
  

	*	 Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable
to the Trustee). 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE * 

The following exchanges of a part of this Global Note for an interest in another Global Note or for a Definitive Note, or
exchanges of a part of another Global Note or Definitive Note for an interest in this Global Note, have been made: 
  

									
	 Date of Exchange
	  	 Amount of

decrease in

Principal
 Amount at

maturity of this
 Global
Note
	  	 Amount of

increase in

Principal
 Amount at

maturity of
 this
Global
 Note
	  	 Principal Amount

at maturity of this
 Global
Note
 following such

decrease
 (or
increase)
	  	 Signature of

authorized
 officer of
Trustee
 or Custodian

  

 

	*	 This schedule should be included only if the Note is issued in global form.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]